Physician profile
Mark S Talbert
NPI 1336170299
$2,177.44
in general payments reported to CMS, 2019-2025
22 companies · $89.78 in 2025
The $89.78 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $1,498 · 2021: $131 · 2022: $85.72 · 2023: $106 · 2024: $24.89 · 2025: $89.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Senseonics, Incorporated | $1,440.00 | 2020 | |
| Axonics, INC. | $119.59 | 2021-2023 | Axonics |
| Kci USA, INC. | $75.73 | 2019-2021 | |
| Boston Scientific Corporation | $60.64 | 2019-2021 | |
| Urogen Pharma, INC. | $47.29 | 2023-2024 | Jelmyto |
| Ethicon US, LLC | $43.85 | 2019 | |
| Innovation Technologies INC | $40.81 | 2020-2023 | Irrisept |
| Teleflex LLC | $39.57 | 2021-2023 | Urolift |
| Organogenesis INC. | $34.94 | 2019 | |
| Medtronic, INC. | $32.59 | 2025 | Interstim |
| Solventum Corporation | $28.69 | 2025 | V.A.C.Ulta |
| Laborie Medical Technologies Corp. | $28.50 | 2025 | |
| Novartis Pharmaceuticals Corporation | $24.29 | 2019 | |
| Davol INC. | $23.30 | 2020 | |
| Innocoll Pharmaceuticals Limited | $22.61 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $21.39 | 2021 | |
| Medtronic USA, INC. | $19.91 | 2019 | |
| Olympus America INC. | $18.55 | 2023 | Soltive |
| Smith+Nephew, INC. | $16.63 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $14.27 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.70 | 2019 | |
| Neotract INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Talbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.